Is a complete SNOA research report available?

No complete published report is available for Sonoma Pharmaceuticals, Inc. (SNOA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Sonoma Pharmaceuticals, Inc. (SNOA)

NASDAQ: SNOA · USD

$1.14

-0.02 (-1.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first SNOA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	5.5M
Revenue (ttm)	19.5M
Net income (ttm)	-3.2M
EPS (ttm)	-$1.89
Shares out	4.8M
Volume	59,072
Beta	1.27

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 19.5M
Net income (ttm): -3.2M
EPS (ttm): -$1.89
Market cap: 5.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All SNOA indicators

Market & fundamental data

Available fields

212

Groups with data

Currency

USD

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001367083
Company name	Sonoma Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	83558L303
Employees	10
Employees Change	2%
Employees Change Percent	25
Enterprise value	$3.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	126.3
Industry PE Fwd	14.06
IPO Date	2007-01-25
Isin	US83558L3033
Last refreshed	2026-07-27
Market cap	$5.5M
Market cap category	Nano-Cap
Price	$1.14
Price currency	USD
Rev Per Employee	1,952,900x
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	3841
Symbol	SNOA
Website	https://sonomapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-58.19%
EV Sales Forward	0.18x
EV/Sales	0.2x
FCF yield	-75.61%
P/B ratio	0.66x
P/S ratio	0.28x
PS Forward	0.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-12.6%
EBITDA Margin	-11.89%
Gross margin	37.97%
Gross Profit	$7.4M
Gross Profit Growth	35.68%
Gross Profit Growth Q	42.74%
Gross Profit Growth3 Y	18.32%
Gross Profit Growth5 Y	2.48%
Net Income	$-3.2M
Net Income Growth Quarters	3%
Net Income Growth Years	3%
Pretax Margin	-17.51%
Profit Margin	-16.26%
Profit Per Employee	$-317,500
ROA	-11.12
Roa5y	-16.89
ROCE	-26.96
ROE	-84.6
Roe5y	-70.56
ROIC	-35.55

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-48.28%
Cagr15y	-45.41%
Cagr1y	-69.3%
Cagr3y	-63.15%
Cagr5y	-61.46%
EPS Growth Quarters	4
EPS Growth Years	8
Revenue Growth	36.68x
Revenue Growth Q	48.14x
Revenue Growth Quarters	7x
Revenue Growth Years	2x
Revenue Growth3 Y	13.74x
Revenue Growth5 Y	0.95x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.41
Assets	$14M
Cash	$2.4M
Current Assets	$12.1M
Current Liabilities	$4.8M
Debt	$842,000
Debt Equity	$0.27
Equity	$3.1M
Liabilities	$10.9M
Long Term Assets	$1.9M
Long Term Liabilities	$6M
Net Cash	$1.6M
Net Cash By Market Cap	$28.54
Net Cash Growth	-69.28%
Net Debt Equity	$-0.5
Tangible Book Value	$3.1M
Tangible Book Value Per Share	$1.72
WACC	9.74

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.5
Inventory Turnover	3.69
Net Working Capital	$5.2M
Quick ratio	1.04
Working Capital	$7.3M
Working Capital Turnover	$2.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-35.7%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.86%
1Y total return	-69.27%
200-day SMA	2.54
3Y total return	-95%
50-day SMA	1.16
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.15%
All Time High	72,323.4
All Time High Change	-100%
All Time High Date	2007-07-17
All Time Low	0.85
All Time Low Change	34.1%
All Time Low Date	2026-04-24
ATR	0.06
Beta	1.27
Beta1y	1.8
Beta2y	1.74
Ch YTD	-68.68
High	1.18
High52	6.92
High52 Date	2025-08-14
High52ch	-83.53%
Low	1.11
Low52	0.85
Low52 Date	2026-04-24
Low52ch	34.1%
Ma50ch	-1.3%
Premarket Change Percent	0
Premarket Price	$1.16
Price vs 200-day SMA	-55.07%
RSI	39.83
RSI Monthly	30.75
RSI Weekly	29.04
Sharpe ratio	-0.75x
Sortino ratio	-1.26
Total Return	-35.7%
Tr YTD	-68.68
Tr15y	-99.99%
Tr1w	-5.79%
Tr3m	-36.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-2.5M
Operating margin	-12.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,765,778%
Float Percent	99.58%
Net Borrowing	6,000
Shares Insiders	0.42%
Shares Institutions	1.43%
Shares Out	4,785,801
Shares Qo Q	1.28%
Shares Yo Y	35.7%
Short Float	1.04%
Short Ratio	0.28
Short Shares	1.04

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-4.4M
Average Volume	110,547.65x
Bv Per Share	1.72
CAPEX	$-192,000
Ch10y	-99.86
Ch15y	-99.99
Ch1w	-5.79
Ch1y	-69.27
Ch3m	-36.67
Ch3y	-95
Ch5y	-99.15
Ch6m	-66.76
Change	-1.72%
Change From Open	-3.39
Close	1.16
Days Gap	1.72
Depreciation Amortization	139,000
Dollar Volume	67,342.1
Earnings Date	2026-08-10
Earnings Time	amc
EBIT	$-2.5M
EBITDA	$-2.3M
EPS	$-1.89
F Score	1
FCF	$-4.1M
FCF EV Yield	-105.8x
FCF Per Share	$-0.86
Financing CF	477,000
Fiscal Year End	March
Founded	1,999
Income Tax	$-244,000
Investing CF	-192,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-06-16
Last Report Date	2026-03-31
Last Split Date	2024-08-30
Last Split Type	Reverse
Last10k Filing Date	2026-06-16
Ma150	2.16
Ma150ch	-47.15%
Ma20	1.21
Ma20ch	-5.79%
Net CF	-2,975,000
Next Earnings Date	2026-08-06
Open	1.18
Optionable	No
Position In Range	42.86
Post Close	1.14
Postmarket Change Percent	-0.88
Postmarket Price	$1.13
Ppne	912,000
Pre Close	1.16
Price Date	2026-07-24
Ptbv Ratio	1.76
Relative Volume	0.53x
Revenue	19,529,000x
SBC By Revenue	1.31x
Share Based Comp	255,000
Tax By Revenue	-1.25x
Tr6m	-66.76%
Us State	Colorado
Volume	59,072
Z Score	-18.4

Sonoma Pharmaceuticals, Inc. (SNOA)

Coverage state: Market snapshot only — no published research

Generate the first SNOA analysis

Price

Financial snapshot

Fair-value bridge

Latest news · SNOA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNOA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SNOA

Frequently asked questions